A Research Trial of High Dose Vitamin C and Chemotherapy for Metastatic Pancreatic Cancer
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
This study is designed to determine the maximum tolerated dose of vitamin C when given with a
standard chemotherapy for people who have metastatic pancreatic cancer.
Phase:
Phase 1
Details
Lead Sponsor:
Joseph J. Cullen
Collaborators:
Holden Comprehensive Cancer Center University of Iowa